Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takuma Kato

Showing results (141-150 of 190) with videos related to

Pageof 19
Sort By:
International Journal of Clinical Oncology|May 20, 2022
Real-world analysis of apalutamide-associated skin adverse events in Japanese patients with advanced prostate cancer: a multi-institutional study in the Chu-shikoku Japan Urological ConsortiumYoichiro Tohi, Takuma Kato, Hideo Fukuhara, et al.
Scientific Reports|June 14, 2019
Infiltrating CCR2<sup>+</sup> monocytes and their progenies, fibrocytes, contribute to colon fibrosis by inhibiting collagen degradation through the production of TIMP-1Naoki Kuroda, Masahiro Masuya, Isao Tawara, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2008
Differential regulatory function of resting and preactivated allergen-specific CD4+ CD25+ regulatory T cells in Th2-type airway inflammationKanako Saito, Mie Torii, Ning Ma, et al.
International Journal of Clinical Oncology|June 9, 2026
Volume-adjusted p2PSA-derived indices for predicting prostate cancer: the PROPHET studyMasaki Shiota, Yoshitaka Sekine, Shoji Tokunaga, et al.
Annals of Gastroenterology|April 10, 2014
Effect of cold ischemia/reperfusion injury and/or shear stress with portal hypertension on the expression of matrix metalloproteinase-9Tomohide Hori, Shinji Uemoto, Feng Chen, et al.
BMC Urology|September 14, 2022
Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)-a prospective single-arm interventional studyMikio Sugimoto, Takuma Kato, Yoichiro Tohi, et al.
The Journal of Clinical Investigation|June 24, 2006
In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccinesHiroyoshi Nishikawa, Eiichi Sato, Gabriel Briones, et al.
International Journal of Clinical Oncology|July 31, 2024
Long-term outcomes of the first prospective study of active surveillance for prostate cancer in JapanTakuma Kato, Hiromi Hirama, Toshiyuki Kamoto, et al.
International Journal of Clinical Oncology|March 25, 2026
Prognostic value of the modified Glasgow Prognostic Score and Prognostic Nutritional Index in prostate cancer treated with cabazitaxelTakuma Kato, Yoichiro Tohi, Atsushi Takamoto, et al.
International Journal of Clinical Oncology|August 20, 2025
Impact of body mass index on the efficacy of immune combination therapy in metastatic renal cell carcinoma: a multicenter study in JapanToshiki Anami, Takanobu Motoshima, Yuto Matsushita, et al.
Pageof 19

Showing results (141-150 of 190) with videos related to

Sort By:
Pageof 19
International Journal of Clinical Oncology|May 20, 2022
Real-world analysis of apalutamide-associated skin adverse events in Japanese patients with advanced prostate cancer: a multi-institutional study in the Chu-shikoku Japan Urological ConsortiumYoichiro Tohi, Takuma Kato, Hideo Fukuhara, et al.
Scientific Reports|June 14, 2019
Infiltrating CCR2<sup>+</sup> monocytes and their progenies, fibrocytes, contribute to colon fibrosis by inhibiting collagen degradation through the production of TIMP-1Naoki Kuroda, Masahiro Masuya, Isao Tawara, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 5, 2008
Differential regulatory function of resting and preactivated allergen-specific CD4+ CD25+ regulatory T cells in Th2-type airway inflammationKanako Saito, Mie Torii, Ning Ma, et al.
International Journal of Clinical Oncology|June 9, 2026
Volume-adjusted p2PSA-derived indices for predicting prostate cancer: the PROPHET studyMasaki Shiota, Yoshitaka Sekine, Shoji Tokunaga, et al.
Annals of Gastroenterology|April 10, 2014
Effect of cold ischemia/reperfusion injury and/or shear stress with portal hypertension on the expression of matrix metalloproteinase-9Tomohide Hori, Shinji Uemoto, Feng Chen, et al.
BMC Urology|September 14, 2022
Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)-a prospective single-arm interventional studyMikio Sugimoto, Takuma Kato, Yoichiro Tohi, et al.
The Journal of Clinical Investigation|June 24, 2006
In vivo antigen delivery by a Salmonella typhimurium type III secretion system for therapeutic cancer vaccinesHiroyoshi Nishikawa, Eiichi Sato, Gabriel Briones, et al.
International Journal of Clinical Oncology|July 31, 2024
Long-term outcomes of the first prospective study of active surveillance for prostate cancer in JapanTakuma Kato, Hiromi Hirama, Toshiyuki Kamoto, et al.
International Journal of Clinical Oncology|March 25, 2026
Prognostic value of the modified Glasgow Prognostic Score and Prognostic Nutritional Index in prostate cancer treated with cabazitaxelTakuma Kato, Yoichiro Tohi, Atsushi Takamoto, et al.
International Journal of Clinical Oncology|August 20, 2025
Impact of body mass index on the efficacy of immune combination therapy in metastatic renal cell carcinoma: a multicenter study in JapanToshiki Anami, Takanobu Motoshima, Yuto Matsushita, et al.
Pageof 19